Skip to Content

Ziconotide Pregnancy and Breastfeeding Warnings

Ziconotide is also known as: Prialt

Ziconotide Pregnancy Warnings

Ziconotide has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of embryolethality as evidenced by significant increases in post-implantation loss. Animal maternal toxicity has been reported to have lead to reduced fetal weighs and transient, delayed ossification of the pubic bones. There are no controlled data in human pregnancy. Ziconotide should only be given during pregnancy when benefits outweigh risks.

See references

Ziconotide Breastfeeding Warnings

There are no data on the excretion of ziconotide into human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions due to ziconotide in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Prialt (ziconotide)." Elan Pharmaceutical/Athena Neurosciences Inc, South San Francisco, CA.

References for breastfeeding information

  1. "Product Information. Prialt (ziconotide)." Elan Pharmaceutical/Athena Neurosciences Inc, South San Francisco, CA.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.